Tuesday, November 3, 2026

Samsung Galaxy Crew 2026: How 70 Creators Will Transform Your Experience with Galaxy Products

Samsung launches Galaxy Crew 2026, a program for 70 creators across diverse fields to engage Gen Z through content showcasing Galaxy products.

Big Bang’s G-Dragon Welcomes New Niece: What This Means for His Family

Big Bang's G-Dragon welcomes a niece as his sister, fashion designer Kwon Da-mi, gives birth to her second daughter.

31 Years After His Death, Kim Il Sung Still Central to North Korea’s Identity

Kim Jong-un commemorated the 31st anniversary of Kim Il-sung's death by visiting the Kumsusan Palace of the Sun.

Health

How Samsung Medical Center Reduced Waste by 80%: A Game-Changer in ESG Management

Hospitals face pressure to adopt eco-friendly practices due to rising concerns over waste and disposable items impacting the environment.

Q901: The Promising New Hope for Pediatric Brain Tumors – What You Need to Know About This FDA-Approved Therapy

Qurient, the major shareholder of DongKoo Bio&Pharma, received FDA approval for a pediatric brain tumor trial of Q901.

IKS014 vs. Enhertu: Can This New HER2 ADC Drug Revolutionize Breast Cancer Treatment?

IKS014 shows a 50% objective response rate in HER2-positive breast cancer patients previously treated with Enhertu.

IMB-105: The Next Breakthrough in Autoimmune Disease Treatment?

IMBiologics partners with GC Pharma to develop next-generation autoimmune disease treatments.

How MEDTIS is Revolutionizing Remote Healthcare in Asia: Insights from Health On Cloud’s CEO

Trust is essential for Korean medical technology to enter foreign markets, according to Jeon Sang-hoon, CEO of Health On Cloud.
Latest

How Zymfentra’s Prescription Rates Tripled in January: A Game-Changer for Celltrion

Celltrion's Zymfentra sees a 213% rise in U.S. prescriptions, marking significant growth since its launch, driven by market demand.

AI Kidney: Revolutionizing Kidney Disease Prediction with U.S. Market Launch

Rokit Healthcare has completed certification for its AI kidney disease prediction solution, 'AI Kidney,' for the U.S. market.

Breakthrough Cancer Drug BAL0891: Key Findings to be Revealed at AACR 2026

SillaJen's cancer drug BAL0891 will be presented at the AACR 2026 conference, highlighting its effects on gastric and breast cancer models.

Daewoong’s Hub System Aims to End Drug Shortages With Predictive Data

Daewoong Pharmaceutical is enhancing drug distribution with a data-driven hub system for better inventory management and transparency.

Discover the Future: AI-Powered Endoscopy with WayMed Endo at KIMES 2026

Waycen will unveil its advanced AI endoscope, Waymed Endo, at KIMES 2026, enhancing endoscopic procedures and detection accuracy.

SK Bioscience Pours 4 Billion KRW into RSM01, Accelerating RSV Antibody Trials

SK Bioscience secures funding from the Light Foundation to support clinical trials for its RSV prevention monoclonal antibody RSM01.

Lunit Scope: How AI Biomarkers Are Revolutionizing Cancer Treatment at AACR 2026

Lunit to present six AI biomarker studies at AACR 2026, showcasing advancements in cancer treatment and AI technology.

How Dongkoo Bio & Pharma Plans to Conquer Southeast Asia’s Aesthetic Market with DERMAROSA

Dongkoo Bio & Pharma partners with Areum Medics and Adization Inc. to expand its global aesthetic market presence with Dermarosa.

AITRICS to Showcase AI Clinical Solutions at KIMES 2026

AITRICS will showcase its clinical AI solutions at KIMES 2026, enhancing healthcare efficiency and patient safety with innovative technologies.

Unlocking Alzheimer’s: The Surprising Role of Tau Protein in Cell Division Revealed

POSTECH researchers reveal tau protein's new role in DNA interaction, impacting Alzheimer's, infertility, and congenital disorders.

Hanskin enters 1,400 Ulta Beauty stores in U.S., expanding North American offline presence

Hanskin expands its North American presence by launching "Hyaluron Skin Essence" in 1,400 Ulta Beauty stores, enhancing brand visibility.

Estipam Secures Record 897 Billion KRW Contract for Oligonucleotide Raw Materials: What This Means for the Asian Market

ST Pharm secures a record 89.7 billion KRW contract for oligonucleotide ingredients, enhancing its global market position.

Discover How MobiCARE’s Wearable ECG Solution Detects Atrial Tachycardia Early

Daewoong Pharmaceutical's mobiCARE device detects atrial tachycardia early, enhancing cardiac health screenings for better patient outcomes.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.